Literature DB >> 30590277

A meta-analysis of executive dysfunction in patients with schizophrenia: Different degree of impairment in the ecological subdomains of the Behavioural Assessment of the Dysexecutive Syndrome.

Maria Lotus Thai1, Anna Krogh Andreassen2, Vibeke Bliksted3.   

Abstract

We performed meta-analyses of studies using the 6 subtests of the neuropsychological test battery, the Behavioural Assessment of the Dysexecutive Syndrome (BADS), in order to assess and compare subdomains of executive dysfunction in stable phase patients with schizophrenia relative to healthy controls. The meta-analyses were performed according to the PRISMA statement. A systematic literature search was performed yielding 10 studies for inclusion (NSCH = 375; NHC = 541). Meta-analyses were done using Stata IC 14. Due to large heterogeneity and the few number of studies a random-effects model was used along with Hedges' g. Results showed that relative to healthy controls, patients with schizophrenia overall performed significantly worse in all subtests of BADS. However, moderate effect sizes were seen with regard to temporal estimation and strategy-forming, while very large effect sizes were seen regarding complex forward planning, inhibition, cognitive flexibility and novel problem solving. The findings from this meta-analysis demonstrate a significant difference between patients with (primarily) longer lasting schizophrenia and healthy control subjects on all subdomains of executive functions (EF). But some aspects of EF seem to be more severely affected than others. Future research and clinical interventions need to differentiate between subdomains of EF.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive flexibility; Inhibition; Organizing; Planning; Problem solving

Mesh:

Year:  2018        PMID: 30590277     DOI: 10.1016/j.psychres.2018.12.088

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

1.  European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Andreas Erfurth; Stefano Barlati; Federico Zanca; Giulia Maria Giordano; Louise Birkedal Glenthøj; Merete Nordentoft; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

2.  Domain-specific cognitive course in schizophrenia: Group- and individual-level changes over 10 years.

Authors:  Camilla Bärthel Flaaten; Ingrid Melle; Thomas Bjella; Magnus Johan Engen; Gina Åsbø; Kristin Fjelnseth Wold; Line Widing; Erlend Gardsjord; Linn-Sofie Sæther; Merete Glenne Øie; Siv Hege Lyngstad; Beathe Haatveit; Carmen Simonsen; Torill Ueland
Journal:  Schizophr Res Cogn       Date:  2022-06-22

3.  Increased thin-spine density in frontal cortex pyramidal neurons in a genetic rat model of schizophrenia-relevant features.

Authors:  A Sánchez-González; E Thougaard; C Tapias-Espinosa; T Cañete; D Sampedro-Viana; J M Saunders; R Toneatti; A Tobeña; J Gónzalez-Maeso; S Aznar; A Fernández-Teruel
Journal:  Eur Neuropsychopharmacol       Date:  2021-01-21       Impact factor: 4.600

4.  Advanced glycation end products and cognitive impairment in schizophrenia.

Authors:  Akiko Kobori; Mitsuhiro Miyashita; Yasuhiro Miyano; Kazuhiro Suzuki; Kazuya Toriumi; Kazuhiro Niizato; Kenichi Oshima; Atsushi Imai; Yukihiro Nagase; Akane Yoshikawa; Yasue Horiuchi; Syudo Yamasaki; Atsushi Nishida; Satoshi Usami; Shunya Takizawa; Masanari Itokawa; Heii Arai; Makoto Arai
Journal:  PLoS One       Date:  2021-05-26       Impact factor: 3.240

5.  Cognitive Functioning and Schizotypy: A Four-Years Study.

Authors:  Penny Karamaouna; Chrysoula Zouraraki; Stella G Giakoumaki
Journal:  Front Psychiatry       Date:  2021-01-08       Impact factor: 4.157

Review 6.  Counterfactual thinking in psychiatric and neurological diseases: A scoping review.

Authors:  Sofia Tagini; Federica Solca; Silvia Torre; Agostino Brugnera; Andrea Ciammola; Ketti Mazzocco; Roberta Ferrucci; Vincenzo Silani; Gabriella Pravettoni; Barbara Poletti
Journal:  PLoS One       Date:  2021-02-16       Impact factor: 3.240

7.  Nature and Correlates of Executive Dysfunction in Schizophrenia: An Exploratory Study.

Authors:  Joseph Noel; Shonima A Viswanathan; Anju Kuruvilla
Journal:  Indian J Psychol Med       Date:  2020-08-10

Review 8.  Neuregulin 1: an intriguing therapeutic target for neurodevelopmental disorders.

Authors:  Liang Shi; Clare M Bergson
Journal:  Transl Psychiatry       Date:  2020-06-16       Impact factor: 6.222

9.  The French Integrative Psychosocial Rehabilitation Assessment for Complex Situations (FIPRACS): Modelization of an Adapted Assessment Method Toward Long-Term Psychiatric Inpatients With Disabling, Severe and Persistent Mental Illness.

Authors:  Christophe Clesse; S Salime; I Dumand; S Barbier Concetta-Ciciarelli; S Lavenir; K Kacemi; P Heckel-Chalet; Frank Sissung; Aurore Poinsignon; Anthony Simon; M Decker; M Batt
Journal:  Front Psychiatry       Date:  2020-09-18       Impact factor: 4.157

10.  Investigating the Relationships of P3b with Negative Symptoms and Neurocognition in Subjects with Chronic Schizophrenia.

Authors:  Giulia M Giordano; Andrea Perrottelli; Armida Mucci; Giorgio Di Lorenzo; Mario Altamura; Antonello Bellomo; Roberto Brugnoli; Giulio Corrivetti; Paolo Girardi; Palmiero Monteleone; Cinzia Niolu; Silvana Galderisi; Mario Maj
Journal:  Brain Sci       Date:  2021-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.